throbber
SURFACTANT SYSTEMS
`
`Their clzcrni.m'y. phurrnuc_y and biology
`
`PAGE 1 OF 98
`
`SENJU EXHJBIT 2043
`
`LUPIN V SENJU
`
`IPR2015—0l105
`
`

`
`SURFACTANT SYSTEMS
`
`Their chemistry, pharmacy and biology
`
`D. Attwood
`Depahhment of Pharmacy A
`University of Manchester
`
`A. T. Florence
`
`Department of Pharmacy
`University of Strathclyde
`
`LONDON
`
`NEW YORK
`
`CHAPMAN AND HALL
`
`PAGE 2 OF 98
`
`

`
`
`7 F974
`74
`
`First published 1983 by
`Chapman and Hall Ltd
`11 New Fetter Ixme, London EC4P 4EE
`Published in the USA by
`Chapman and Hall
`
`7
`
`/
`
`733 Third Avenue, New York NY 10017
`
`(C) 1983 D. Attwood and A. T. Florence
`
`Printed in Great Britain by
`J. W Arrowsmilh Ltd, Bristol
`
`ISBN 0 412 14840 4
`
`All rights reserved. No part of this book may be reprinted, or
`reproduced or utilized in any form by any electronic, mechan-
`ical or other means, now known or hereafter invented, includ-
`ing photocopying and recording, or in any information storage
`and retrieval system, without permission in writing from the
`Publisher.
`
`
`
`British Library Cataloguing in Publication Data
`
`Attwood, D.
`Surfactant systems.
`1. Surface active agents
`
`ll. Florence, A. T.
`1. Title
`TP994
`668’.l
`ISBN 0-412-14840-4
`
`R! R
`(
`(J '\\‘.
`’] \ \
`
`PAGE 3 OF 98
`
`

`
`6 Pharmaceutical aspects of
`solubilization
`
`6.1 Introduction
`
`Solubilization in surfactant solutions above the critical micelle concentration
`offers one approach to the formulation of poorly soluble drugs in solution form
`1
`.
`‘
`
`[ Jfhe objective ofthis chapterand ofChapter 7 is to review the state ofthe art of
`
`solubilization in surfactant systems with emphasis on the consequences of a
`surfactant presence in pharmaceutical formulations. In particular, emphasis will
`be‘ placed on the effect of surfactants on bioavailability and the toxicity of
`formulations for neglect of these topics will, on the one hand, prevent the
`realization of the potential of surfactant systems and, on the other, might lead to
`the unwise use of surfactants in formulations. Some attempt will be made to place
`the topic in perspective and to answer the question as to the real value of
`surfactant solubilization in pharmaceutical formulation.
`It is perhaps true that micellar solubilization has not made much impact on
`drug formulation. There are relatively few marketed products which could be
`considered to be isotropic solutions of drug and surfactant in either the UK or the
`USA, although surfactants are present in many formulations as minor adjuvants
`and to that extent their presence and influence is perhaps hidden.
`- The limiting factors in the use of solubilizers as effective formulation aids are (i)
`the finite capacity of the micelles for the drug, (ii) the possible short- or long-term
`adverse effects of the surfactant on the body, and (iii)
`the concomitant
`solubilization of other ingredients such as preservatives, flavouring and colouring
`matter in the formulation with consequent alterations in stability and effective-
`ness. Nonetheless,-thcrc is scope for development simply because there is a need
`for agents to increase the solubility of poorly soluble drugs even if only at the
`stageiof vpharmaoological evaluation where, indeed, surfactants are used often
`without due regard to the implications. The use of co-solvents and surfactants to
`'solve 1-problems of low solubility has the advantage that the drug entity can be
`used without chemical modification and hence toxicological data do not have to
`r berepeated as would be the case when alternative approaches are used to produce
`-more soluble compounds. Some caution has, however, to be adopted in the
`
`293
`
`PAGE 4 OF 98
`
`

`
`294
`
`‘ Surfactant systems
`
`interpretation of animal pharmacology and toxicology on formulations which
`differ from the final marketed product, especially if the final preparation contains
`surfactant but early test formulations do not or vice versa. Surfactants. as we will
`see in Chapter 7, are not inert substances some having distinctive pharmaco-
`logical actions. There is a demonstrable need for the development of less toxic
`surfactants; the polyoxyethylene—polyoxypropylene block co-polymers which
`will be discussed later seem to have fewer side effects than conventional
`surfactants and seem to be worthy of further investigation.
`With the development ofnew dosage form technology in which control ofdrug
`release is achieved, it is conceivable that micellar systems will find some place
`because of the ability of the micellar phase to alter the transport properties of
`solubilized drug molecules. One can envisage the deliberate addition of
`surfactants to drug reservoirs to control the exit rate of drugs from polymeric
`devices. This will be explained in Chapter 7.
`This chapter is restricted mainly to aqueous systems and the solubilization of
`water-insoluble and poorly soluble drug entities and pharmaceutical additives,
`and, because of the lesser toxicity of non-ionic surfactants, it will concentrate on
`non-ionic surfactant systems. Wherever possible cited work refers to systems
`which have potential utility in pharmacy as there is a danger that all our
`knowledge is gained on model systems (of toxic ionic surfactants which are used
`because they are available in a pure state. benzene or similar well-defined solutes,
`and other unacceptable additives such as propanol) while we remain blissfully
`unaware of how to solve the real problems that arise [1].
`As we have seen in Chapter 1, the range of available surfactants is wide, and so,
`too, are the mechanisms of solubilization and the effects the surfactants have on
`
`the solubilized material. Examples are known of enhanced drug activity and of
`inactivation, of increased stability. and instability;
`the interactions of the
`surfactants with components of the body must also be considered. In the case of
`insoluble drugs, the presence of micelles may enhance their activity through
`solubilization and transport to the site of action, a process which otherwise might
`have been a slow one. This has, of course, dire consequences in the ease of
`carcinogens: normally insoluble carcinogenic substances which may be ingested
`may become very active in combination with surfactants, and, as the latter are
`taken in increasing amounts in food (non-ionics in bread is one example), this isa
`problem which warrants further study. Drugs which are meant to act on the
`intestinal mucosa, such as sulphaguanidine, might be inadvertently solubilized.
`There is the problem. especially with non-ionic surfactants. of interactions with
`preservatives in pharmaceuticals and consequent loss-of biological action."
`.Some drugs themselves are surface-active and form micelles. While surface
`activity may. not, in all cases, be the cause of their biological activity-, «it mustin
`some way influence it and modify their interaction with the _components.of
`dosage forms or the components of the body. Surface-active drugs and-surfactant
`molecules will interactto form mixed micelles at sufficiently high concentrations,
`a phenomenon which has implications for the thermodynamic activity and
`possibly the biological activity of the drug molecule.
`
`PAGE 5 OF 98
`
`

`
`Pharmaceutical aspects of so/ubilization
`
`-
`
`295
`
`Since 1964 there have been several comprehensive reviews of solubilization in
`surfactant systems, notably those by Swarbrick [2], Mulley [3], Sjoblom [4],
`Droseler and Voight [5], Elworthy et al. [6], and Florence
`These reviews
`together cite over a thousand sources primarily concerned with pharmaceutical
`applications. Other major publications which deal with micellar systems
`implicating solubilized species include Cordes [7], Fendler and Fendler [8] and
`the collections of papers edited by Mittal contain several contributions on the
`topic [9].
`In this chapter the solubilization of a number of classes of drugs and
`pharmaceutical products will be dealt with; in some cases the division into
`sections has had to be somewhat arbitrary, but, as far as possible, compounds
`with similar structures, such as the steroids, have been dealt with as a group.
`
`6.2 Solubilization of drugs
`
`6.2.1 Antibacterial compounds
`
`(A) PHENOLIC COMPOUNDS
`Solutions of cresol with soap were early pharmaceutical examples of solubilized
`systems. Phenol itself is soluble in water to the extent of 7.7% (w/v), but it has
`disadvantages; the alternatives, cresol, chlorocrcsol, chloroxylenol, and thymol,
`are much less soluble in water, and their use as disinfectants has led to the need for
`
`fprmulation in surfactant solutions.
`Solution of cresol with soap (lysol) is a saponaceous solution containirrg 50%
`v/v cresol. Its monograph specifies no particular soap, although activity of the
`preparation depends to a large extent on the type of soap employed. Although
`still used, the absence of strict standards for lysol, the widely varying phenol
`fractions used in its preparation, and the varying properties of the soaps make it
`an unsatisfactory solution. The high toxicity of phenol and the cresols has
`mitigated against their more widespread use. Emphasis is now being placed on
`their chlorinated derivatives, chloroxylenol and chlorocresol. Chloroxylenol is a
`potent, non-irritant bactericide of low toxicity. It has, however. a low solubility in
`water, 0.031 gml' ‘ at 20°C [10];
`the oflicial preparation, Solution of
`Chloroxylenol B.P., contains 5 "/0 v/v chloroxylenol with terpineol in an alcoholic
`soap solution. A modification of this, claimed to be less alkaline, has been
`described by Lloyd and Clegg [1 1]. There are numerous commercial formu-
`lations with a wide spread of Rideal—Walker coeflicients.
`Mulley and Metcalf [12] have carried out detailed investigations of the phase
`behaviour of non-ionic detergent systems containing chloroxylenol (4-cl1loro-
`3,5-xylenol). Two of their phase diagrams are reproduced in Fig. 6.1. The
`surfactant C611, ,(OCH2CH2)6OH is an efficient solubilizer above its CMC,
`which is approximately 3% w/w, but high concentrations are required to form
`isotropic
`liquids
`containing
`reasonable
`quantities
`of
`chloroxylenol.
`C51-l,3(OCH;CH2)2OH requires concentrations above 50% w/w to achieve an
`isotropic solution, and this compound probably acts more as a hydrotrope than
`
`in ‘ PAGE 6 OF 98
`
`

`
`296
`
`-
`
`Surfactant systems
`
`as a micellar solubilizer in this concentration region. The former detergent forms
`only small aggregates ofabout 13 monomers in aqueous solution [13]. To obtain
`systems suitable for use it
`is essential
`to increase the alkyl chain length;
`C,0H2 1 (OCHzCH,)6OH has a low CMC and its micelles are reasonably large,
`containing 73 monomers at 25°C [14]. Isotropic micellar systems are formed at
`lower concentrations of detergent than for the shorter alkyl-chain homologues,
`However, there is a concomitant increase in the complexity of the phase diagram
`with the formation of liquid crystalline phases (Fig. 6.1).
`There is apparently no evidence from these phase diagrams for the existence of
`simple phenol—glycol chain complexes: the liquid which separates at a solubility
`limit is a solution of variable composition. Ultraviolet spectroscopy shows that a
`hydrogen-bonded complex between the phenolic hydroxyl group and the other
`oxygens of cetomacrogol 1000 (C,5H,3(OCH,CH,),3_.,,,OH) is formed when
`chloroxylenol
`is solubilized by this commercial non-ionic surfactant. The
`
`C§H‘3iOCHzCHz)x OH
`
`Water
`
`Chloroxylenol
`
`Figure 6.1 The upper phase diagram (after Mulley and Mctcalf [l2]) illustrates the
`phases existent in the system C,H, _, (OCH, CH,), OH: 4—chloro-3,5-xylenol: water at
`20° C.The dotted line represents the behaviour when x = Zand thesolid lines where x = 6.
`The lower diagram shows the much more complex behaviour
`in the system:
`C“, H,, (0CH,CH,)6OH: chloroxylenol: water.
`I1. = isotropic liquid; LC = liquid
`crystalline; S = solid 2L = two liquids (immiscible.)
`
`PAGE 7 OF 98
`
`

`
`7-—:—-—-——
`
`Pharmaceutical aspects of solubilization
`
`-
`
`297
`
`to the surfactant
`is directly proportional
`solubility of the chloroxylenol
`concentration, above the CMC [l5]. However, rough determinations of the
`solubilities of resorcinol and phenol
`in cetomacrogol solutions. varying in
`concentration from I to 20 "/,,,showed these compounds to be less soluble than in
`water, although their solubility was proportional to detergent concentration
`16]-
`
`[ Solutions ofphenols in ionic systems exhibit similar behaviour. An initial fall in
`
`in potassium laurate
`the solubility of 2-hydroxyphenol and 4-benzylphenol
`solutions was noted below the CMC of the soap [17]. Few workers have
`commented on this ‘insolubilization‘; compounds with very low water solubility
`possibly do not show this property. That it is not restricted to phenols is shown by
`the results of Heller and Klevcns [18] for ethyl benzene in potassium laurate.
`Ethyl benzene has a solubility in water similar to that of 4-benzylphenol.
`The binding of series of phenols, cresols and xylenols to the non-ionic
`surfactant cetomacrogol 1000 can be described by a Langmuir adsorption
`isotherm [19]
`
`X = KlK2C“1
`
`where x is the solute bound (mmol g" micelle), c is the concentration of free
`unionized solute (mmol), K 1 is the binding constant (1 mmol ‘ ‘) and K 2 the solute
`bound at hypothetical saturation (mmol g’ ‘ micelle). The combined parameter
`K 1 K2 is specific for each system and may be defined as the distribution coefficient
`of the solubilizate at infinitely dilute solubilizate concentration (Po), Azaz and
`Donbrow [19] assert. Its value characterizes ideal behaviour both in the aqueous
`and mieellar phases hence strictly would be subject
`to activity corrections.
`Binding capacity is inversely related to the water solubility of the phenoL cresol
`and xylenol, as can be seen in Table 6.1.
`Values of P0 in 0.1 M NaCl are also shown for a few compounds in this Table. A
`log——log plot of binding capacity and aqueous solubility yields a straight line. A722
`
`Table 6.1 Aqueous solubility and distribution coefficient at infinite dilution (Po) between
`cetomacrogol and water of phenols at 25° C
`
`Compound
`
`Phenol
`a~Cresol °'
`p-Cresol
`m-Cresol
`2,4-Xylenol
`2,6-Xylenol
`3,5-Xylenol
`3.4-Xylenol
`2,3-Xylenol
`2.5-Xylenol
`
`Solubility in water
`(mol l‘ ‘ x 10’)
`
`P0 in water‘
`
`Solubility in 0.1 M P0 in 0.1 M
`NaCl3 (mol|"
`NaCl‘
`x 10 )
`
`233
`I 88
`I 33
`
`117
`80.6
`
`1000
`240
`199
`142
`SLO
`49.5
`40.0
`39.0
`37.4
`29.0
`
`42.0
`79.5
`76.4
`85.1
`125
`1 14
`132
`151
`169
`197
`
`° PMS! (1/8) X 10’ = 1/1000s or dimensionless units assuming density of cetomacrogol is unity at
`25 C. Measured in 2% cetomacrogol. From Azaz and Donbrow [19].
`
`PAGE 8 OF 98
`
`

`
`298
`
`-
`
`Surfactant systems
`
`and Donbrow’s work has supported earlier work [20—23] which demonstrated
`that in unsaturated systems the binding ‘constants’ of solubilizates to surfactants
`are concentration-dependent and not, in fact, constant as some authors have
`assumed (e.g. [24—26] ). This variation may have important practical implications
`in formulation.
`
`A wider range of 34 benzoic acid derivatives has been studied in detail by
`Tomida et al. [27]. Using a solubility method these workers obtained saturation
`solubilities of the benzoic acid derivatives in Brij 35 (a polyoxyethylene lauryl
`ether) over a range of concentrations. Solubility ratios, calculated as the solubility
`in the surfactant solution/solubility in HC1, were a linear function of surfactant
`concentration allowing the calculation of a partition coetficient Pm which can b_c
`defined as
`
`Cm
`P = —,
`..
`Ca
`
`6.
`
`(
`
`1)
`
`where Cm and C, are the concentrations in the miocllar and aqueous phases,
`respectively. Pm is obtained from the solubility data as
`
`St
`
`S.
`
`= (Pm — 1)rC, +1
`
`(6.2)
`
`where S. is the total solubility of solubilimte in the presence of surfactant at
`concentration C.,S. is the solubility in the absence of surfactant and 5 is the
`partial molar volume of the surfactant. Some of the extensive data is reproduced
`in Table 6.2 for the ortho, para and meta substituents. The data are consistent
`with the findings of Azaz and Donbrow: the order of aqueous solubilities ‘is
`always ortho > meta > para and the order of Pm is the opposite except for the
`hydroxybenzoic acids for which the ortho compound was solubilized most,
`followed by para and meta compounds. Patel and Foss [21] obtained the
`
`Table 6.2 Aqueous solubilities. S.. and partition coefficients of benzoic acids. P.,,hetwee_n
`aqueous and micellar phases obtained from solubility method‘
`_.
`.
`~_
`
`Substituent
`
`ortho
`
`meta
`
`para
`
`S,(moll“)
`
`Pm
`
`S,(rnoll“)
`
`Pm
`
`S,(mo1l")
`
`Pm
`
`57.4
`2.61 x 10"
`H
`94.6
`4.98 X10"
`91.2
`1.65 X10"
`F
`446
`3.48 X 10"
`346
`1.92 X 10‘3
`Cl
`634
`1.42 X 10"‘
`505
`1.36 X 10"
`B1’
`908
`9.16 X10-6
`1150
`2.74 X10-‘
`1
`I63
`2.23-x 10"
`166
`6.13 X10"
`CH,
`109
`1.30 X 10"
`72.8
`1.18 X 10’;
`OCH,
`42.2
`4.17 x 10"
`38.3
`5.71 X 10-3
`CH
`117
`1.01 X 10"’
`96.8
`1.57 X 10"
`NO;
`CN
`2.35 x 10"
`50.1
`5.60 x 10" 3
`57.0
`COOH
`2.57 X 10"
`22.4
`4.42 X 10"
`155
`6.50 x 10"
`69.8
`
`
`c
`
`4.05 X10”
`8.66 X 10"
`5.29 X104
`1.75 X10"
`6.55 X 10"’
`2.50 x 10"
`1.08 X10"
`2.53 X10-2
`
`43.1
`99.8
`150
`271
`120
`32.0
`116
`47.5
`
`‘ From [27].
`
`PACE 5 OF 98
`
`

`
`'-1';-———-——
`
`Pharrnaceuzical aspects ojsoluhilizariori
`
`-
`
`299
`
`magnitude of interaction of hydroxy-, chloro- and aminobenzoic acids in
`polysorbate 80 and eetomacrogol 1000; hydroxy and amino derivatives showed
`the order of interaction to be ortho > para > meta. Substitution of a hydroxy
`group in the ortho position results in more alfinity for any surfactant than para
`and meta substituents. This can be explained by the fact that the intramolecular
`hydrogen bonding increases the proton-donating nature ofthe carboxylic group.
`The greater the dissociation constant of the acid group the greater the hydrogen
`bonding to the oxyethylene groups in the micelle.
`Plots of log Pm versus log P,.c._,,,(,. for the 34 compounds studied produced three
`groupings of results [27] to which the following equations applied.
`n
`r
`5
`
`log Pm = 0.921 log P.,..,,,,.,. + 0.112 21
`
`0.986
`
`0.080
`
`log Pm = 0.881 log P.,c..,,.,. +0392 5
`
`0.999
`
`0.014
`
`log Pm = 0.968 log Poctanol + 0.600
`
`3
`
`0.999
`
`0.036
`
`(6.3)
`
`(6.4)
`
`(6.5)
`
`where n is the number of points used in the regression, r is the correlation
`coefficient, and sis the standard deviation. Equation 6.3 applies to the majority of
`the compounds studied; Equation 6.4 to the nitro and cyano derivatives and the
`last equation to the compounds with diearboxylic groups. The intercept values of
`the three groups are quite different; it is believed that the magnitude of the
`intercept is a reflection of the site of solubilization in the micelle. The closer the
`environment is to the nature of oetanol used in the partitioning studies to obtain
`Pm, the closer the intercept should be to zero. A negative intercept (for salicylic
`acid derivatives) has been identified with solubilization in the hydrocarbon core.
`The site of solubilization while of little practical importance in the design of
`pharmaceutical formulations is of more than academic interest as the position of
`the solubilizate in the micelle may determine its stability and reactivity towards
`attacking species in the continuous phase (see Chapter 11).
`To obviate the problem of the different affinities of ionized and unionized
`species for micelle, Tomida er al. [27] carried out their investigations at a pH such
`that ionization was suppressed. pH is rarely as low as that in this work and its
`influence on solubilization must be considered. Although the hydrogen ion
`V concentration can influence the solution properties of non—ionic surfactants [28],
`the principal influence on uptake is exercised through the effect of pH on the
`equilibrium between ionized and unionized drug or solute species. This effect has
`been studied in most detail by Collett and [(00 [29]. Increasing pH leads to a
`decrease in the micellar uptake of organic acids because of increasing solute
`solubility in the aqueous phase through increased ionization. This effect is clearly
`seen in Fig. 6.2 when the results of uptake of 4-chlorobenzoic acid between pH 3
`and 4.40 are plotted as a ratio of its solubility in water of the appropriate pH, i.e.
`as the solubility ratio R. Considering the micellar species to form a phase or
`pseudophase allows a simple quantitative measure of the interaction between
`solubilizate and micelle. The concentration of solubilizate in the micelle is related
`
`to its concentration in the aqueous phase by a partition coeificient as defined in
`Equation 6.1.
`
`PAGE10oF9s
`
`

`
`300
`
`-
`
`Surfactant systems
`
`on
`
`3.0
`
`3.4
`
`3.62
`
`4.0
`4.15
`
`4.4
`
`I2
`
`e
`
`is
`
`1
`
`E
`
`2
`
`E3
`
`33I
`
`D
`
`
`
`1
`
`3
`2
`Polysorbore concn
`
`a x 1o"<mou 1")
`
`Figure 6.2 The influence of polysorbate 20 concentration and pi! on the solubility ratio,
`R, of 4-chlorobenzoic acid. From Collett and Koo [29].
`
`Curved Scatchard plots for the interaction of propyl p-hydroxybenzoale
`(propyl paraben) with four polyoxyethylene dodecyl ethers are shown in Fig. 6.3
`[31]. The primary class of binding sites exhibited a high affinity and a low
`capacity for the preservative while the secondary sites had a low affinity and large
`binding capacity. This
`-
`
`"1 K ID!
`(555?
`V -W + MK: [Prl
`Analysis of these has allowed ‘n , , n,, K , and K 1 to be’ estimated and related to the
`nature of the binding ‘process in the micelles, especially in respect of the
`interaction with the hydrophilic polyoxyeth'ylene lay'er"j[32].
`Qf great practical'i'rnporta'nce are t-he effects of additives on the binding of
`preservative molecules 'to- surfactant micelles. ‘Blanchard et al., [33] have
`confirmed the negligible effect of sorbitol on the interaction of phenolic
`preservatives with polysorbate 80 using a Scatchard approach. The sorbitol is
`probably too hydrophilic to interact with the micelle and thus does not compete
`for binding sites. Similar conclusions were reached by Shimamoto and Mirna [34]
`studying-the effects of glycerol, propylene glycol and 1,3-butylene glycol on
`paraben-Anon-ionic surfactant interactions. These polymers had little effect on the
`binding of preservatives to the primary binding sites located at the core/PEG
`boundary of the micelle but they were ‘thought to decrease binding at the
`secondary sites,
`l,3—butylene glycol" being most effective in displacing the
`preservatives: These secondary sites are reckoned to be non-specific and located
`in the PEG layer. As materials such as 1,3-butylene glycol may penetratethe PEG
`region they would probably displace solubilizate molecules. It would seem that
`displacement from the primary site would require much greater structural
`specificity (see discussion on interaction of preservative mixtures with micelles‘,
`
`-
`
`n
`
`PLACE; 1l1mOll7 98 _
`
`

`
`Pharmaceutical aspects of solubilizalion
`
`-
`
`301
`
`Figure 6.3 Scatchard plots for the interaction of propyl paraben with polyoxyethylene
`dodecyl ethers, n being the number of oxyethylene units.
`On=l5;On=20;An=30;An=50
`From [31] with permission.
`
`below). Any displacement of preservative from the micelle is likely to increase the
`preservative activity of the formulation.
`The effects of added electrolytes on solubilized systems are discussed in
`Chapter 5. In Table 6.1 it can be seen that‘the addition of sodium chloride to a
`non-ionic system increases the Pm of the solubilizate. An electrolyte can have a
`dual effect, first on the properties of the surfactant and secondly on the
`solubilizate. If the electrolyte salts out the solubilizate Pm will increase, an effect
`observed with non-ionic surfactant systems whose micelles would-be increased in
`size by such electrolytes. In ionic surfactant systems the effect can be more
`complex. The addition of electrolyte to an ionic surfactant results in a decrease in
`CMC, increase in micellar size and a decrease in effective charge per monomer,
`probably leading to a greater concentration of head groups and a more rigid
`micellar interior [35] which might result in decreased uptake of solubilizate into
`the micellar core. Uptake ofmethyl and ethyl paraben is increased by the addition
`of 10 mM NaCl to sodium lauryl sulphate [36] (see Table 6.3} As both electrolyte
`and the presence of paraben lowers the surfactant CMC, analysis of the results
`produced the unexpected conclusion that for all three compounds the partition
`coefficient to the micellar phase is reduced on addition of electrolyte. This is a
`problem which occurs and recurs in detailed studies of mechanisms of
`solubilization, being clearest when pH effects are studied. Generally the
`formulator is interested in total solubility which includes solubility in the aqueous
`and micellar phases. While the partitioning of a species to the micellar phase
`might be reduced, its increased solubility in the aqueous phase may compensate
`for this. ln spite of the partition coefficient of the methyl, ethyl and butyl paraben
`
`PAGE 12 OF 98
`
`

`
`302
`
`~
`
`Surfactant systems
`
`Table 6.3 Solubilization of alkylparabens in water and in 40 mm sodium
`lauryl sulphate solution at 27° C‘.
`
`Alkylparaben
`
`Solubility (mmol l ' ’) in
`
`Water
`
`:10mM NaLS
`
`2
`
`40mM NaLS and
`so mM NaCl
`
`Methylparaben
`Ethylparaben
`Butylparaben
`
`l4.5
`5.4
`1.1
`
`‘ From [36, 38].
`
`33.9
`22.7
`24.3
`
`31.6
`2 l .9
`26.7
`
`increasing towards the micellar phase from 1.2 through 3.2 to 21, respectively, in
`40 mM sodium lauryl sulphate (NaLS) the total solubility is still highest for
`methyl paraben with a solubility limit of 33.9 mM. Ethyl paraben has the lowest
`solubility (22.7 mM)and butyl paraben has a solubility of 24.3 mM in 40 mM NaLS
`[38]. In a series such as the alkyl parabens their different locations in the micelle
`may be another factor complicating a ready understanding of the observation; the
`effect of the paraben on CMC which follows the order butyl > ethyl
`> methylparaben is of little importance when the total surfactant concentration
`is 40 mM as in the investigations in question but would obviously be important at
`surfactant concentrations close to the concentration (Fig. 6.4 shows this elfect).
`Uptake ofsolubilizate into surfactant micelles changes the physical state of the
`micelle (see Section 5.5). Sometimes the change in shape may result in drastic
`changes in the physical properties of the system as a whole — this may influence its
`use. The effect of additive on the cloud point of non-ionic surfactants
`
`I 9X o2U
`
`4
`
`6 3
`[0,] x lo M
`
`B
`
`‘IO
`
`12
`
`Figure 6.4 The CMCs of sodium lauryl sulphate solutions in the presence of alkyl
`parabens. O, methylparaben; O, ethylparaben; x, butylparaben. From Goto and Endo
`[37] with permission.
`
`

`
`Pharmaceutical aspects of solubilization
`
`-
`
`303
`
`60
`
`0
`
`
`
`Cloudpoinr(°C) 8on
`
`Figure 6.5 Relation between the cloud point and P, values for phenol and its homologues
`at concentrations of 0.05 mol l" in 2%. cetomacrogol 1000. From Donbrow and Azaz
`[43]. Values of P0 from Table 6.1.
`
`[3942] is of some practical importance as the cloud point may be lowered
`below room temperature. Fig. 6.5 shows the eifect of a range of phenols on
`the cloud point of cetomacrogol solutions (cetornacrogol 1000 B.P.
`is
`C,5H,3(OCH,CH,),,_ 1.011) where the relation between cloud point and the
`distribution coefficient of phenols, cresols and xylenols between micelles and
`water is demonstrated. The effect of a phenol on the cloud point is inversely
`related to its hydrophilicity. As the cloud point is thought to be due to the growth
`of the non-ionic micelles with increasing temperature, the binding of solute to the
`rnicellar structure could explain the lowering of the cloud point if the surfactant
`monomer—solute complex is more hydrophobic than the surfactant monomer
`itself.
`
`Phenol—water systems display critical solution temperatures (CST). Addition
`of fatty acid soaps generally causes a lowering of CST. 3 "/0 sodium oleate lowers
`the CST of the phenol—water mixture from ~ 65 to 0° C [45]. 17,, lowers it to
`43°C and 1% sodium stearate lowers it
`to 49.l° C [46]. Prins [44]
`in
`investigations on cetyltrimethylammonium bromide (CTAB)—phenol—watet
`mixtures, found striking effects caused by the detergent on the CST of the
`phenol—water system. Table 6.4 gives the concentrations of CTAB and phenol
`which have in admixture with water a CST of 20° C. The figures were obtained
`from a study of the phase diagram of the system.
`
`Table 6.4 Concentrations of Cl"AB and phenol
`having a critical solution temperature of 20° C‘
`
`CTAB (% w/w)
`
`Phenol ("/o w/w)
`
`8.0
`17.5
`28.0
`34.0
`40.5
`41.5
`40.0
`
`‘ From Prins
`
`I 1.0
`16.8
`25.2
`31.7
`35.6
`41.0
`45.1
`
`PAGE 14 OF 98
`
`

`
`304
`
`'
`
`Surfactant systems
`
`Cetyltrimethylammonium bromide has a more complicated action than the fatty
`acid soaps. Although it generally enhances the mutual solubility of phenol and
`water, at some levels it has been shown to decrease the mutual solubility. Addition
`ofmore CTABcauses the mutual solubility to increase again until at 48 ‘Z, CTAB,
`complete miscibility is attained. Prins has gone some way to explaining this
`behaviour. When phenol is added to an aqueous solution of CTAB consisting of
`spherical micelles the phenol induces the formation of rod-shaped aggregates (see
`simplified phase diagrams in Fig. 6.6).
`
`CYAB
`
`Spherical micelles
`:2 Rod-shaped micelles
`
`'3 Molecular dispersion
`
`PHENOL
`
`cetyltrimcthylammonium
`the
`of
`reprcsenta_tion
`6.6 A diagrammatic
`Figure
`bromide—phenol—water system. (After Prins [44]). Horizontal arrow shows increasing
`phenol concentrations and passage from solutions containing spherical micelles, through
`solutions containing asymmetric micelles to a molecular dispersion on breakdown of the
`micelles.
`
`The rod-shaped micelles can solubilizc large quantities of phenol, but they
`reach a point (b) where they disintegrate, forming a molecular dispersion which
`results in a loss of mutual solubility. All systems containing more than 48 ‘)1,
`CTAB are completely miscible. Examination of the interfacial tension curve of
`the co-existent phases in the water—phenol—CTAB system (phenolzwater 40: 60 by
`weight) shows that the curve mimics the solubility behaviour. A minimum at
`about 4 "/0 is followed by an increase in interfacial tension, which falls again after
`15 ‘X, concentration, falling to 0 mN in “ at about 40 %.
`
`INTERACTION OF PRESERVATIVE MIXTURES WITH SURFACTANTS.
`(B)
`In many formulations more than one solute will be a potential solubilizate
`whether or not this is desired. As discussed in Chapter 5, the effect, if any, of one
`solute on the solubilization of another will depend on the mechanisms of
`solubilization. If solubiliuition of one solute occurs at specific ‘sites’ within the
`micelles then molecules with similar binding affinities might compete for the
`available sites leading to a decreased solubilization of each. In some cases one
`solute might induce a reorganization of the micelle structure and allow increased
`uptake; both mechanisms might operate such that maxima and minima are seen
`in the plots of solubility versus the concentration of second solubilizatc [47] (see
`Fig. 5.23). Bcnzoic acid, for example, increases the solubility of methyl paraben in
`
`PAGE 15 OF 98
`
`

`
`Pharmaceutical aspects of solubilization
`
`-
`
`305
`
`cctomacrogol solutions, but dichlorophenol decreases its solubilization [47].
`Chloroxylenol reduces the solubility of methylparaben and methylparaben
`reduces the solubility of chloroxylenol in cetomacrogol, there being no effect on
`mutual solubilities in the absence of surfactant.
`The distribution of a solubilizate between micelles and the aqueous phase does
`not obey necessarily a simple partition law when a second solubilizate is present
`[48]. A non-linear increase in solubilization with increasing surfactant concen-
`tration has been found with a second solubili7ate present. Fig. 6.7 shows the
`change in micellar partition coefficient of o-hydroxybenzoic acid in the presence
`of increasing levels ofbenzoic acid when polysorbate 80 is the solubilizer [48]. At
`1 "/0 surfactant there is a marked decrease in partition coefficient, but at 3 ‘X, there
`is little change. Nalidixic acid does not alter the micellar distribution coefficient of
`0-hydroxybcnzoic acid but chloramphenicol reduces the distribution. Nalidixic
`acid has no detectable effects on the cloud point of the polysorbate solutions,
`suggesting that it does not alter micellar structure. Alhaique et at. [48] conclude
`that if the added compound does not induce significant changes in micellar
`structure it will not alter the distribution into the micelle of another solubilizate;
`this problem requires further and more detailed examination, primarily because
`of its importance in pharmaceutical systems and because of the potential
`importance of the phenomenon in altering drug bioavailability from micellar
`systems. Preliminary work on permeation through polymer membranes [48] has
`shown that the reduction in permeation caused by solubilization of a solute can
`
`0O
`
`8
`
`A
`EV
`..
`r:
`_o
`.9
`3.‘tv
`0L’
`
`:o
`
`'2
`'2I-
`0Q
`
`L 3
`
`.’o
`3i
`
`2T
`
`i
`L’
`2
`
`‘
`2
`1
`Added species (Mx‘lO )
`
`3
`
`Figure 6.7 Changes in micelle/water apparent partition coefficie

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket